Bristol Will Buy Diabetes Drug Maker

Bristol-Myers Squibb said it will buy diabetes drug maker Amylin in a $7 billion deal that will intensify the competition to treat the growing number of people afflicted with the disease.

ASK NEWS:
  • Diabetes Drug Market 2016 Research in-Depth Analysis, Disease, ... - Medagadget.com
    Liquid Chromatography Instruments Market 2016 Market Share, Industry ... - International Business Times
    08/19/2016 - 4:32 am | View Link
  • More
BING NEWS:
  • AstraZeneca to Buy Bristol’s Stake in Diabetes Joint Venture
    AstraZeneca (AZN) agreed on Thursday to buy Bristol-Myers Squibb’s ... an advisory panel recommended that the U.S. Food and Drug Administration approve dapagliflozin, an experimental treatment for Type 2 diabetes. A similar treatment from Johnson ...
    12/19/2013 - 8:03 pm | View Link
  • AstraZeneca to buy Bristol out of diabetes venture for up to $4.1 billion
    Speculation that AstraZeneca might look to buy out Bristol was fuelled last month ... received a boost when an advisory panel to the U.S. Food and Drug Administration endorsed its new diabetes pill dapagliflozin.
    12/18/2013 - 5:54 pm | View Link
  • AstraZeneca to buy Bristol out of diabetes venture for up to $4.1 billion
    The move will bulk up AstraZeneca's thin drug portfolio and give Bristol ... Speculation that AstraZeneca might look to buy out Bristol was fuelled last month when the U.S.-based company decided to get out of diabetes research. The decision to quit ...
    12/18/2013 - 3:39 pm | View Link
  • Bristol-Myers starts process of buying Amylin stock
    Bristol-Myers Squibb is starting a tender offer to buy all of the outstanding shares of diabetes drug maker Amylin Pharmaceuticals Inc. Late last month, Bristol-Myers Squibb said that it planned to buy San Diego-based Amylin for approximately $5 billion in ...
    07/9/2012 - 11:55 pm | View Link
  • Bristol-Myers to buy diabetes drug maker for $5 billion
    Bristol-Myers Squibb Co. said it plans to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash. Bristol-Myers will enter an agreement with British drug maker AstraZeneca to develop and commercialize Amylin's diabetes drugs, the ...
    07/1/2012 - 7:04 pm | View Link
  • More
BING SEARCH:
  • Press Announcements
    Note: Press announcements from 2004 to 2012 are available through the FDA Archive. Some links in press announcements may no longer be active. For more information ...
    08/25/2016 - 7:58 am | View Website
  • League | Frontier League
    © Frontier League. All rights reserved. Website Powered by
    08/25/2016 - 2:07 am | View Website
  • Bristol-Myers Squibb
    Bristol-Myers Squibb, often referred to as BMS, is an American pharmaceutical company, headquartered in New York City. Bristol-Myers Squibb manufactures prescription ...
    08/25/2016 - 12:13 am | View Website
  • BMY Stock Quote
    AstaZeneca stock rises 2.2% after Bristol-Myers lung cancer drug trial failure. 9:32 a.m. Aug. 5, 2016 - Emma Court
    08/24/2016 - 9:07 pm | View Website
  • Stock Quote BMY Bristol-Myers Squibb Company
    Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
    08/24/2016 - 5:25 pm | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News